AIDS Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Nucleic Acid Vaccines
Self-Replicating RNA Vaccine for Cancer, Disease Therapy
August 23rd, 1999
A self-replicating RNA vaccine not only protected mice against tumor challenge but also improved survival in mice with established tumors. The vaccine "self replicates" by borrowing a replicase polyprotein derived from Semliki forest virus. The replicase (Rep-LacZ) drives replication of the RNA to which it is linked. This greatly increases the amount of vaccine-encoding RNA within the target cell. The vaccine's extraordinary efficacy, however, is not a direct result of extra antigen: in vitro studies showed that it produced only a little more than twice as much antigen as a conventional DNA vaccine. Instead, the self-replicating vaccine...
Source: AIDS Weekly (1999-08-23)
|
